banner
Renin-angiotensin-aldosterone system (RAAS) inhibitor Aliskiren hemifumarate, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ565

Renin-angiotensin-aldosterone system (RAAS) inhibitor Aliskiren hemifumarate, Purity ≥98%

Synonym: 173334-58-2; Renin-angiotensin-aldosterone system (RAAS) inhibitor

  • CAS Number: 173334-58-2
  • Compound CID: 6918427
img
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Aliskiren hemifumarate, soluble in DMSO, water and ethanol, regulates blood pressure and fluid balance by blocking the effects of the RAAS pathway, which plays a critical role in the body’s cardiovascular health. It targets Renin.
Molecular Weight
609.8
Molecular Formula
C30H53N3O6.1/2C4H4O4
Targets
Renin: 1.5 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 89 mg/mL (145.94 mM); Water: 89 mg/mL (145.94 mM); Ethanol: 89 mg/mL (145.94 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Aliskiren hemifumarate is employed in cardiovascular research to inhibit the RAAS pathway, primarily for its role in managing high blood pressure.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0